Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pyridostigmine bromide (substance) |
Is a |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigmine measurement |
Component |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine adverse reaction |
Causative agent (attribute) |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine allergy |
Causative agent (attribute) |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pyridostigmine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing pyridostigmine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pyridostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine bromide 5mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigmine bromide 5mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigmine allergy |
Causative agent (attribute) |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine bromide (substance) |
Is modification of (attribute) |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pyridostigmine 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pyridostigmine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pyridostigmine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pyridostigmine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |